MedPath

A study to evaluate the effect of intake of Ubiquinol on the status of stress and sleep in adult workers.

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000032233
Lead Sponsor
TTC Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who are diagnosed melancholy by BDI-II. 2) Subjects who are 0mm as a result of VAS stress . 3) Subjects who routinely use food or medicine containing of Ubiquinol. 4) Night and day shift worker or manual laborer. 5) Subjects who have a disease on treatment or are judged to that medical treatment are necessary by the doctor. 6) Subjects who are under treatment or a history of sleep apnea syndrome or are strongly suspected of having sleep apnea syndrome. 7) Subjects diagnosed with chronic fatigue syndrome. 8) Subjects who were under treatment or have a history of serious diseases (e.g., diabetes, liver disease, kidney disease, or heart disease). 9) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire and other questionnaires. 10) Those who can not carry out the procedures of various tests to be carried out during this study. 11) Subjects having possibilities for emerging allergy related to the study. 12) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination. 13) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study. 14) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. 15) Subjects who are judged as unsuitable for the study by the investigator for other reason.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath